These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of high-risk corneal grafts. Coster DJ; Williams KA Eye (Lond); 2003 Nov; 17(8):996-1002. PubMed ID: 14631407 [TBL] [Abstract][Full Text] [Related]
6. Tissue barriers, immunosuppressive microenvironments, and privileged sites: the eye's point of view. Streilein JW Reg Immunol; 1993; 5(5):253-68. PubMed ID: 8148235 [TBL] [Abstract][Full Text] [Related]
7. Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors. Mrass P; Weninger W Immunol Rev; 2006 Oct; 213():195-212. PubMed ID: 16972905 [TBL] [Abstract][Full Text] [Related]
8. A vision of cell death: Fas ligand and immune privilege 10 years later. Ferguson TA; Griffith TS Immunol Rev; 2006 Oct; 213():228-38. PubMed ID: 16972907 [TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells and transplantation tolerance. Cobbold SP J Nephrol; 2008; 21(4):485-96. PubMed ID: 18651537 [TBL] [Abstract][Full Text] [Related]
11. Latanoprost does not affect immune privilege of corneal allografts. Wang M; Kitahara Y; Yoshida A; Hori J Exp Eye Res; 2008 Feb; 86(2):394-402. PubMed ID: 18187130 [TBL] [Abstract][Full Text] [Related]
12. See no evil, hear no evil, do no evil: the lessons of immune privilege. Niederkorn JY Nat Immunol; 2006 Apr; 7(4):354-9. PubMed ID: 16550198 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts. Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003 [TBL] [Abstract][Full Text] [Related]
14. Review of ocular immune privilege in the year 2010: modifying the immune privilege of the eye. Hori J; Vega JL; Masli S Ocul Immunol Inflamm; 2010 Oct; 18(5):325-33. PubMed ID: 20849282 [TBL] [Abstract][Full Text] [Related]
15. History and physiology of immune privilege. Niederkorn JY; Stein-Streilein J Ocul Immunol Inflamm; 2010 Jan; 18(1):19-23. PubMed ID: 20128645 [TBL] [Abstract][Full Text] [Related]
16. The testis in immune privilege. Fijak M; Meinhardt A Immunol Rev; 2006 Oct; 213():66-81. PubMed ID: 16972897 [TBL] [Abstract][Full Text] [Related]
17. The liver: a special case in transplantation tolerance. Benseler V; McCaughan GW; Schlitt HJ; Bishop GA; Bowen DG; Bertolino P Semin Liver Dis; 2007 May; 27(2):194-213. PubMed ID: 17520518 [TBL] [Abstract][Full Text] [Related]
18. The taming of the shrew? The immunology of corneal transplantation. Pleyer U; Schlickeiser S Acta Ophthalmol; 2009 Aug; 87(5):488-97. PubMed ID: 19664109 [TBL] [Abstract][Full Text] [Related]
19. Research on HLA-G: an update. Favier B; LeMaoult J; Rouas-Freiss N; Moreau P; Menier C; Carosella ED Tissue Antigens; 2007 Mar; 69(3):207-11. PubMed ID: 17493143 [TBL] [Abstract][Full Text] [Related]
20. The tumor-draining lymph node as an immune-privileged site. Munn DH; Mellor AL Immunol Rev; 2006 Oct; 213():146-58. PubMed ID: 16972902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]